Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval
A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of experimental medicines, as the Associated Press has reported. The FDA approved the drug from Amylyx Pharmaceuticals based … Read more